Carl Spana
Net Worth
Last updated:
What is Carl Spana net worth?
The estimated net worth of Dr. Carl Spana is at least $20,366,158 as of 27 Dec 2022. He owns shares worth $27,158 as insider and has received compensation worth at least $20,339,000 in Palatin Technologies, Inc..
What is the salary of Carl Spana?
Dr. Carl Spana salary is $924,500 per year as Co-Founder, Pres, Chief Executive Officer & Director in Palatin Technologies, Inc..
How old is Carl Spana?
Dr. Carl Spana is 63 years old, born in 1962.
What stocks does Carl Spana currently own?
As insider, Dr. Carl Spana owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Palatin Technologies, Inc. (PTN) | Co-Founder, Pres, Chief Executive Officer & Director | 288,604 | $0.09 | $27,158 |
What does Palatin Technologies, Inc. do?
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.